Publication: SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
dc.contributor.author | Guisado Hernández, Paloma | |
dc.contributor.author | Blanco Lobo, Pilar | |
dc.contributor.author | Villaoslada, Isabel | |
dc.contributor.author | de Felipe, Beatriz | |
dc.contributor.author | Lucena, José M | |
dc.contributor.author | Martín Gutierrez, Guillermo | |
dc.contributor.author | Castro, María José | |
dc.contributor.author | Gutiérrez Valencia, Alicia | |
dc.contributor.author | Sánchez Codez, María Isabel | |
dc.contributor.author | Gaboli, Mirella | |
dc.contributor.author | Neth, Olaf | |
dc.contributor.author | Olbrich, Peter | |
dc.date.accessioned | 2023-02-09T11:40:18Z | |
dc.date.available | 2023-02-09T11:40:18Z | |
dc.date.issued | 2021-06-09 | |
dc.identifier.doi | 10.1007/s10875-021-01081-9 | |
dc.identifier.essn | 1573-2592 | |
dc.identifier.pmc | PMC8189704 | |
dc.identifier.pmid | 34109505 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189704/pdf | |
dc.identifier.unpaywallURL | https://link.springer.com/content/pdf/10.1007/s10875-021-01081-9.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/17982 | |
dc.issue.number | 7 | |
dc.journal.title | Journal of clinical immunology | |
dc.journal.titleabbreviation | J Clin Immunol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Puerta del Mar | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Puerta del Mar | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 1502-1506 | |
dc.pubmedtype | Case Reports | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Child | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Interferon-Stimulated Gene Factor 3 | |
dc.subject.mesh | Janus Kinases | |
dc.subject.mesh | Mutation | |
dc.subject.mesh | Nitriles | |
dc.subject.mesh | Pyrazoles | |
dc.subject.mesh | Pyrimidines | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Severity of Illness Index | |
dc.subject.mesh | COVID-19 Drug Treatment | |
dc.title | SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance? | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 41 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1